The US Food and Drug Administration has cleared the extended-wear Dexcom G7 device for adult users The Dexcom G7 continuous glucose monitor (CGM) will now
ViCentra B.V., the company behind Kaleido, the insulin patch pump and automated insulin delivery (AID) system, has announced the appointment of Tom Arnold as Chief
ViCentra has announced that its Kaleido insulin pump has received CE certification under the EU Medical Device Regulation. The Kaleido pump includes two durable pumps,
Technology has come a long way since the first blood glucose meter was developed in 1965. Now, diabetes patients have access to continuous glucose monitors
The first phase of the roll-out of hybrid closed loop systems to NHS integrated care systems continues. Following a successful pilot by NHS England, in
Glooko, Inc. and Hedia have launched an innovative interoperable solution designed to improve diabetes management. The solution integrates connected care, remote patient monitoring, and digital
SNAQ, a food-based diabetes management app, has announced the launch of an AI-powered meal glucose prediction feature, which allows individuals using continuous glucose monitors (CGMs)
Medtronic has issued an “Urgent Medical Device Correction” about the accuracy of insulin pump delivery during changes in air pressure, such as plane takeoffs and
Vertex has announced that its Phase 1/2 trial for its VX-880 stem cell-derived islet therapy is converting to a Phase 1/2/3 pivotal trial, enrolling 50
US-based biotech company Sana Biotechnology has released clinical data showing that the first person receiving engineered islets from deceased donors is now producing insulin without
